Safety and efficacy of sonographically guided random core biopsy for diffuse liver disease.
Publication/Presentation Date
8-1-2000
Abstract
Sonographic guidance is commonly used in the biopsy of focal hepatic lesions, but biopsy for diffuse disease is often non-image-guided. We evaluated the safety and efficacy of real-time sonographically guided random core biopsy in the assessment of diffuse liver disease in 210 patients. The two most common indications for biopsy were viral hepatitis (in 113 patients) and elevated liver function test results of unknown cause (in 54 patients). Ultrasonography and pathology reports were reviewed retrospectively to determine number of needle passes and final diagnoses. Adequate tissue was obtained in all 210 patients, with 259 of 269 (96%) passes having been successful. Specimens were submitted for light microscopy and other tests as indicated. No difference in success rates was found for right and left lobe biopsies. No major complications occurred. Minor complications occurred in 10 of 210 (4.8%) patients and were self-limited. Sonographically guided core liver biopsy is a safe and effective method for the diagnosis of liver disease.
Volume
19
Issue
8
First Page
537
Last Page
541
ISSN
0278-4297
Published In/Presented At
Nazarian, L. N., Feld, R. I., Herrine, S. K., Webner, D., Lev-Toaff, A. S., Johnson, P. T., Storey, L. A., & Needleman, L. (2000). Safety and efficacy of sonographically guided random core biopsy for diffuse liver disease. Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine, 19(8), 537–541. https://doi.org/10.7863/jum.2000.19.8.537
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
10944039
Department(s)
Administration and Leadership
Document Type
Article